动脉瘤治疗前蛛网膜下腔出血患者的高血压管理
本文综述动脉瘤治疗前蛛网膜下腔出血患者的高血压管理,指出该阶段缺乏高级别循证指南,临床实践存在差异。现有推荐虽合理,但需更大规模研究明确降压治疗对结局的影响及血压阈值。
要点
- 动脉瘤治疗前蛛网膜下腔出血高血压管理缺乏高级别循证指南。
- 需平衡降低血压以减少再出血风险与避免脑灌注不足致缺血损伤。
- 当前推荐在指南建立前似乎合理,但需进一步大规模研究。
核心结论
- 进一步、更大规模的研究是必要的,以明确降压治疗对患者结局的影响、血压阈值以及开始降压治疗的最佳方案。
研究设计与样本
- 本文为文献综述,检索范围未具体报告。
主要发现
- 彻底审查未发现管理这些患者的高级别循证指南,导致不同临床医生和机构间的临床实践存在差异。
关键数值与推荐
- 当前推荐涉及某些参数(如平均动脉压、收缩压),但具体数值未在摘要中报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 缺乏高级别循证指南。
- 进一步、更大规模的研究是必要的,以明确降压治疗对患者结局的影响、血压阈值以及开始降压治疗的最佳方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Management of hypertension in subarachnoid hemorrhage patients within the preaneurysmal treatment period remains ambiguous, in part due to the lack of high-level, evidence-based guidelines. Despite this, current recommendations offer guidance regarding certain parameters (e.g., mean arterial pressure, systolic blood pressure). However, managing hypertension within this critical period is difficult because a fine balance must be achieved between lowering blood pressure enough to minimize the risk of rebleeding and preventing reduced cerebral perfusion and subsequent ischemic damage. Furthermore, the different causes of hypertension within the preaneurysmal treatment period are polyfactorial and include pathophysiologic responses, sympathetic nervous system activation, and iatrogenic from hyperdynamic therapy and vasopressors, which requires consideration for these patients to receive optimal management. Other factors including loss of autoregulation and concomitant conditions must also be considered when deciding whether to start antihypertensive therapy. METHODS: We review the literature and provide a comprehensive update on management of hypertension within the preaneurysmal treatment period, which we hope stresses the need for better evidence-based guidelines that will in turn help manage this cohort. RESULTS: Thorough review revealed no high-grade, evidence-based guidelines to manage these patients, which results in variation in clinical practice among different clinicians and institutions. Despite this, current recommendations seem reasonable until such guidelines are established. CONCLUSIONS: It is clear that further, larger studies are warranted in order to clarify the effect of antihypertensive therapy on patient outcome and what the BP thresholds are, along with establishing the best treatment, for commencing antihypertensive therapy.
引用
- Hall A, O'Kane R. The Management of Hypertension in Pre-Aneurysmal Treatment Subarachnoid Hemorrhage Patients. World Neurosurg. 2019. PMID: 30825622. doi:10.1016/j.wneu.2019.02.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。